Literature DB >> 14703975

Osteoblastic differentiation bioassay and its application to investigating the activity of fractions and compounds from Psoralea corylifolia L.

Z Xiong1, D Wang, Y Xu, F Li.   

Abstract

A cell differentiation bioassay measuring alkaline phosphatase activity was developed using osteoblast-like UMR 106 cell line as a model. The effect of fractions and compounds of Psoralea corylifolia L. extract on osteoblastic differentiation was investigated. The fractions or compounds were co-cultured with cells for 48 h, the cellular ALP activity was then measured. The crude ethanol extract of Psoralea corylifolia L. increased ALP activity by 39.5% at a concentration of 0.1 mg/ml, and the activity was concentrated in the ethyl acetate fraction, which produced a maximum ALP activity increase of 38.2%. A significant activity was observed for a flavonoid, corylin, providing 30.0% increment in ALP. These effects suggest that Psoralea corylifolia L. extract, its ethyl acetate fraction and corylin would stimulate bone formation.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14703975

Source DB:  PubMed          Journal:  Pharmazie        ISSN: 0031-7144            Impact factor:   1.267


  9 in total

1.  Psoralidin, an herbal molecule, inhibits phosphatidylinositol 3-kinase-mediated Akt signaling in androgen-independent prostate cancer cells.

Authors:  Raj Kumar; Sowmyalakshmi Srinivasan; Srinivas Koduru; Pallab Pahari; Jürgen Rohr; Natasha Kyprianou; Chendil Damodaran
Journal:  Cancer Prev Res (Phila)       Date:  2009-02-17

2.  Psoralen stimulates osteoblast proliferation through the activation of nuclear factor-κB-mitogen-activated protein kinase signaling.

Authors:  Feimeng Li; Qihuo Li; Xiaoqing Huang; Yunting Wang; Chana Ge; Yong Qi; Wei Guo; Hongtao Sun
Journal:  Exp Ther Med       Date:  2017-07-11       Impact factor: 2.447

3.  The Effect of Salt-Processed Psoralea corylifolia on Generative Organ Targeting.

Authors:  Gen-Hua Zhao; Cui-Ping Yan; Zi-Sheng Xu; Qian-Qian Gao; Zhi-Peng Chen; Wei-Dong Li
Journal:  J Anal Methods Chem       Date:  2016-10-20       Impact factor: 2.193

4.  Evaluation on Antimicrobial Activity of Psoraleae semen Extract Controlling the Growth of Gram-Positive Bacteria.

Authors:  Sejeong Kim; Soomin Lee; Heeyoung Lee; Jimyeong Ha; Jeeyeon Lee; Yukyung Choi; Hyemin Oh; Joonbae Hong; Yohan Yoon; Kyoung-Hee Choi
Journal:  Korean J Food Sci Anim Resour       Date:  2017-08-31       Impact factor: 2.622

Review 5.  Natural Products from Chinese Medicines with Potential Benefits to Bone Health.

Authors:  Chun-Tao Che; Man Sau Wong; Christopher Wai Kei Lam
Journal:  Molecules       Date:  2016-02-27       Impact factor: 4.411

6.  Hu-Lu-Ba-Wan Attenuates Diabetic Nephropathy in Type 2 Diabetic Rats through PKC- α /NADPH Oxidase Signaling Pathway.

Authors:  Lishan Zhou; Hui Dong; Yi Huang; Lijun Xu; Xin Zou; Kaifu Wang; Guang Chen; Fuer Lu
Journal:  Evid Based Complement Alternat Med       Date:  2013-06-25       Impact factor: 2.629

7.  Corylin Suppresses Hepatocellular Carcinoma Progression via the Inhibition of Epithelial-Mesenchymal Transition, Mediated by Long Noncoding RNA GAS5.

Authors:  Chi-Yuan Chen; Chin-Chuan Chen; Tzong-Ming Shieh; Chuen Hsueh; Shu-Huei Wang; Yann-Lii Leu; Jang-Hau Lian; Tong-Hong Wang
Journal:  Int J Mol Sci       Date:  2018-01-27       Impact factor: 5.923

8.  Corylin increases the sensitivity of hepatocellular carcinoma cells to chemotherapy through long noncoding RNA RAD51-AS1-mediated inhibition of DNA repair.

Authors:  Chin-Chuan Chen; Chi-Yuan Chen; Shir-Hwa Ueng; Chuen Hsueh; Chau-Ting Yeh; Jar-Yi Ho; Li-Fang Chou; Tong-Hong Wang
Journal:  Cell Death Dis       Date:  2018-05-01       Impact factor: 8.469

9.  In-vitro osteoblast proliferation and in-vivo anti-osteoporotic activity of Bombax ceiba with quantification of Lupeol, gallic acid and β-sitosterol by HPTLC and HPLC.

Authors:  Shashi Chauhan; Aditi Sharma; Navneet Kumar Upadhyay; Gajender Singh; Uma Ranjan Lal; Rohit Goyal
Journal:  BMC Complement Altern Med       Date:  2018-08-07       Impact factor: 3.659

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.